Acidic fibroblast growth factor is a potent mitogen for human dermal fibroblasts in an in vitro three-dimensional collagen matrix, the "dermal equivalent." Both cell numbers and DNA synthesis are optimally stimulated by daily doses of I ng/ml of the pure human mitogen in the presence of heparin, which binds to, and stabilizes, the protein. Under daily treatment by 1 ng/ml aFGF, the fibroblast mitogenic response is marked but transient, and decreases steadily when fibroblasts mature in the collagen matrix, aFGF mitogenic stimulation also results in a decrease in cellular volume and inhibition of fibroblast-mediated contraction of the collagen gel. Various dosing regimes indicate that, although the greatest mitotic response was generated by daily dosing, nearly optimal responses can also be achieved with either a short duration of early daily dosing or longer-term intermittent treatment. © 1991.
CITATION STYLE
Dubertret, L., Brunner-Ferber, F., Misiti, J., Thomas, K. A., & Dubertret, M. L. (1991). Activities of human acidic fibroblast growth factor in an in vitro dermal equivalent model. Journal of Investigative Dermatology, 97(5), 793–798. https://doi.org/10.1111/1523-1747.ep12486796
Mendeley helps you to discover research relevant for your work.